Aminorroaya Ashraf, Amini Massoud, Hovsepian Silva
Isfahan Endocrine and Metabolism Research Center, Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
J Health Popul Nutr. 2010 Aug;28(4):351-8. doi: 10.3329/jhpn.v28i4.6041.
This cross-sectional study investigated the prevalence of goitre in Isfahan, a centrally-located city in Iran, 15 years after the initiation of universal salt iodization. In total, 2,523 Isfahani adults (1,275 males, 1,248 females) aged > 20 years were selected by multi-stage cluster-sampling method. Goitre rate, serum thyroid-stimulating hormone (TSH), thyroxine (T4), thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TgAb), and urinary iodine concentration (UIC) were measured and compared between the goitrous (n = 478) and the non-goitrous (n = 2,045) participants. The total goitre rate was 19% (n = 478) of the 2,523 adults. The rate of Grade I and II goitre was 12.4% (n = 312) and 6.6% (n = 166) respectively. The total goitre rate, Grade I and II goitre were more prevalent among women than among men. Hypothyroidism was observed in 6.4% (130/2,045) and 18.6% (89/478) of the non-goitrous and goitrous participants respectively [odds ratio (OR) = 3.6, 95% confidence interval (CI) 2.7-4.9, p = 0.001]. Hyperthyroidism was present in 0.8% (17/2,045) and 5.2% (29/478) of the non-goitrous and goitrous adults respectively (OR = 9.0, 95% CI 4.9-16.6, p = 0.001). Hypothyroidism was more prevalent in Grade II than in Grade I goitre and among those without goitre (31.3%, 14.1%, and 6.4% respectively) (p = 0.001). Positive TPOAb was observed in 24% (n = 50) of the non-goitrous and 33.5% (n = 84) of the goitrous subjects (p = 0.03). Positive TPOAb was observed in 24.6% (35 of 142) of the Grade I and 45% (49 of 109) of the Grade II goitrous adults (p = 0.001). Positive TgAb was observed in 21.6% (n = 45) of the non-goitrous and 35.9% (n = 90) of the goitrous adults (p = 0.001). Positive TgAb was observed in 30.3% (43 of 142) of the Grade I and 43.1% (47 of 109) of the Grade II goitrous adults (p = 0.04). The median UIC was 18 microg/dL (range 1-80 microg/dL). It was 17.9 microg/dL and 19 microg/dL in the non-goitrous and goitrous adults respectively. After 15 years of successful universal salt iodization in Isfahan, goitre is still endemic, which may be due to thyroid autoimmunity. However, other environmental or genetic factors may have a role.
这项横断面研究调查了伊朗中部城市伊斯法罕在全民食盐加碘开始15年后的甲状腺肿患病率。通过多阶段整群抽样方法,共选取了2523名年龄大于20岁的伊斯法罕成年人(1275名男性,1248名女性)。对甲状腺肿患者(n = 478)和非甲状腺肿患者(n = 2045)测量并比较了甲状腺肿率、血清促甲状腺激素(TSH)、甲状腺素(T4)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TgAb)以及尿碘浓度(UIC)。在2523名成年人中,甲状腺肿总患病率为19%(n = 478)。I级和II级甲状腺肿的患病率分别为12.4%(n = 312)和6.6%(n = 166)。甲状腺肿总患病率、I级和II级甲状腺肿在女性中比在男性中更普遍。在非甲状腺肿参与者和甲状腺肿参与者中,甲状腺功能减退的发生率分别为6.4%(130/2045)和18.6%(89/478)[优势比(OR)= 3.6,95%置信区间(CI)2.7 - 4.9,p = 0.001]。甲状腺功能亢进在非甲状腺肿成年人和甲状腺肿成年人中的发生率分别为0.8%(17/2045)和5.2%(29/478)(OR = 9.0,95% CI 4.9 - 16.6,p = 0.001)。II级甲状腺肿患者中甲状腺功能减退的患病率高于I级甲状腺肿患者以及无甲状腺肿者(分别为31.3%、14.1%和6.4%)(p = 0.001)。非甲状腺肿受试者中TPOAb阳性率为24%(n = 50),甲状腺肿受试者中为33.5%(n = 84)(p = 0.03)。I级甲状腺肿成年人中TPOAb阳性率为24.6%(142例中的35例),II级甲状腺肿成年人中为45%(109例中的49例)(p = 0.001)。非甲状腺肿成年人中TgAb阳性率为21.6%(n = 45),甲状腺肿成年人中为35.9%(n = 90)(p = 0.001)。I级甲状腺肿成年人中TgAb阳性率为30.3%(142例中的43例),II级甲状腺肿成年人中为43.1%(109例中的47例)(p = 0.04)。UIC的中位数为18微克/分升(范围1 - 80微克/分升)。非甲状腺肿成年人和甲状腺肿成年人中的UIC分别为17.9微克/分升和19微克/分升。在伊斯法罕成功实施全民食盐加碘15年后,甲状腺肿仍然是地方病,这可能是由于甲状腺自身免疫。然而,其他环境或遗传因素可能也起作用。